ZIC1
protein-codingZic family member 1, the group of Zinc fingers C2H2-type
Gene summary
This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. Members of this family are important during development. Aberrant expression of this gene is seen in medulloblastoma, a childhood brain tumor. This gene is closely linked to the gene encoding zinc finger protein of the cerebellum 4, a related family member on chromosome 3. This gene encodes a transcription factor that can bind and transactivate the apolipoprotein E gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~116.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014705
Submitter: ClinGen
ZIC1 was first reported in relation to autosomal dominant craniosynostosis 6 in 2015 (Twigg et al., PMID: 26340333). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities craniosynostosis 6 (OMIM: 616602) and structural brain anomalies without craniosynostosis (no OMIM term). The split curation for autosomal recessive structural brain anomalies without craniosynostosis will be curated separately. Ten variants (missense, frameshift, nonsense) that have been reported in at least 17 probands in 8 publications (PMIDs: 26340333, 27884935, 30391508, 32975022, 33288889, 35591945, 36118902, 37086723) are included in this curation. The variants associated with this disease are all in the C-terminal region, the disruption of which enhances en-2 expression. The mechanism of pathogenicity is reported to be gain-of-function. This gene-disease relationship is also supported by experimental evidence (GTEx expression data, Xenopus oocyte functional evidence; PMID: 26340333). In summary, there is definitive evidence supporting the relationship between ZIC1 and autosomal dominant craniosynostosis 6. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 1/18/2024 (SOP Version 10).
Inheritance Pattern: Unknown
Disease ID:MONDO:0032892
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0009072
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014705
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014705
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014705
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032892
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014705
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0032892
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0018114
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZIC1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003412.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 61 | 5 | 67 | ||
| missense | 1 | 5 | 98 | 9 | 5 | 118 |
| nonsense | 2 | 5 | 1 | 8 | ||
| start loss | 0 | |||||
| frameshift | 1 | 5 | 6 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 4 | 10 | 105 | 70 | 10 | 199 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003403.2 | 3 | MANE Select | |
| Ensembl | ENSP00000282928.4 | 3 | MANE Select | |
| Ensembl | ENSP00000419664.1 | 3 | Standard | |
| Ensembl | ENSP00000804494.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| zic1 | Danio rerio | Structure: optic fissure Quality: closure incomplete abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neural Crest Differentiation
- Differentiation of white and brown adipocyte
Biological Process
- pattern specification process
- central nervous system development
- brain development
- adult walking behavior
- regulation of smoothened signaling pathway
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
Cellular Component
- nucleus
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000282928
- Coding exons
- 3
- Length
- 116872
- Individuals with no LoFs
- 123380
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 123381
- p
- 0.00000405
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.57 | 160 | 281 | 0.569 | 0.0000127 | 2935 |
| Missense (PolyPhen) | 57 | 128.05 | 0.44512 | 1389 | ||
| Synonymous | -2.81 | 161 | 122 | 1.32 | 0.00000596 | 889 |
| Loss of Function | 3.09 | 1 | 13.0 | 0.0767 | 5.65e-7 | 138 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a transcriptional activator. Involved in neurogenesis. Plays important roles in the early stage of organogenesis of the CNS, as well as during dorsal spinal cord development and maturation of the cerebellum. Involved in the spatial distribution of mossy fiber (MF) neurons within the pontine gray nucleus (PGN). Plays a role in the regulation of MF axon pathway choice. Promotes MF migration towards ipsilaterally- located cerebellar territories. May have a role in shear flow mechanotransduction in osteocytes. Retains nuclear GLI1 and GLI3 in the cytoplasm. Binds to the minimal GLI-consensus sequence 5'- TGGGTGGTC-3' (By similarity). {ECO:0000250|UniProtKB:P46684}.;
- Disease
- DISEASE: Craniosynostosis 6 (CRS6) [MIM:616602]: A form of craniosynostosis, a primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:26340333}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.281
Intolerance Scores
- LoFtool
- 0.0318
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.09
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.995
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |